Aim: To analyze the quality of life (QoL), work productivity and activity impairment (WPAI)
and healthcare resource utilization (HCRU) in rheumatoid arthritis (RA), psoriatic
arthritis (PsA) and ankylosing spondylitis (AS) patients receiving golimumab ...